Skip to main content
Top
Published in: Critical Care 4/2014

Open Access 01-08-2014 | Research

Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients

Authors: Christabelle J Darcy, Gabriela Minigo, Kim A Piera, Joshua S Davis, Yvette R McNeil, Youwei Chen, Alicia D Volkheimer, J Brice Weinberg, Nicholas M Anstey, Tonia Woodberry

Published in: Critical Care | Issue 4/2014

Login to get access

Abstract

Introduction

Impaired T cell function in sepsis is associated with poor outcome, but the mechanisms are unclear. In cancer, arginase-expressing myeloid derived suppressor cells (MDSCs) deplete arginine, impair T cell receptor CD3 zeta-chain expression and T cell function and are linked to poor clinical outcome, but their role during acute human infectious disease and in particular sepsis remains unknown. Hypoarginemia is prevalent in sepsis. This study aimed to determine whether neutrophils that co-purify with PBMC express arginase, and if arginine depletion constrains T cell CD3 zeta-chain expression and function in human sepsis.

Methods

Using flow cytometry, cell culture, HPLC, arginase activity and mRNA detection, our study examined whether neutrophils, with reduced buoyant density isolated in the Ficoll interface, metabolise L-arginine and suppress T cell proliferation in sepsis. A total of 35 sepsis patients (23 with septic shock) and 12 hospital controls in a tertiary referral hospital in tropical Australia were evaluated.

Results

Only sepsis patients had interphase neutrophils, neutrophils co-purifying with mononuclear cells (≤1.077 specific gravity). The percentage of interphase neutrophils in sepsis was proportional to sepsis severity and correlated with plasma IL-6 concentrations. Ex vivo, sepsis-derived interphase neutrophils expressed arginase, metabolised culture L-arginine and suppressed T cell proliferation and CD3 zeta-chain expression. In vivo, in septic shock there was a longitudinal inverse association between interphase neutrophil number and CD3 zeta-chain expression. Depletion or inhibition of interphase neutrophils in vitro restored zeta-chain expression and T cell function.

Conclusions

For the first time during an acute human infection, interphase neutrophils that express arginase were found to circulate in sepsis, in proportion to disease severity. These neutrophil-MDSCs impair T cell CD3 zeta-chain expression and T cell function via L-arginine metabolism, and likely contribute to the T cell dysfunction seen in sepsis. Modulation of neutrophil-MDSC or their downstream effects warrant consideration as targets for novel adjunctive therapies in sepsis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992, 101: 1644-1655.CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992, 101: 1644-1655.CrossRefPubMed
2.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310.CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310.CrossRefPubMed
3.
go back to reference Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J: Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 2004, 30: 589-596.CrossRefPubMed Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J: Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 2004, 30: 589-596.CrossRefPubMed
4.
go back to reference Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, Collado J, Garcia-Labattut A, Carriedo D, Valledor M, De Frutos M, López MJ, Caballero A, Guerra J, Alvarez B, Mayo A, Villar J, Grupo de Estudios y Análisis en Cuidados Intensivos: Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care. 2008, 12: R158-PubMedCentralCrossRefPubMed Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, Collado J, Garcia-Labattut A, Carriedo D, Valledor M, De Frutos M, López MJ, Caballero A, Guerra J, Alvarez B, Mayo A, Villar J, Grupo de Estudios y Análisis en Cuidados Intensivos: Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care. 2008, 12: R158-PubMedCentralCrossRefPubMed
6.
8.
go back to reference Hotchkiss RS, Monneret G, Payen D: Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013, 13: 260-268.PubMedCentralCrossRefPubMed Hotchkiss RS, Monneret G, Payen D: Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013, 13: 260-268.PubMedCentralCrossRefPubMed
9.
go back to reference Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med. 1997, 25: 1095-1100.CrossRefPubMed Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med. 1997, 25: 1095-1100.CrossRefPubMed
10.
go back to reference Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M: The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med. 1984, 311: 1137-1143.CrossRefPubMed Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M: The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med. 1984, 311: 1137-1143.CrossRefPubMed
12.
go back to reference Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G: High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis. 1998, 26: 1076-1082.CrossRefPubMed Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G: High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis. 1998, 26: 1076-1082.CrossRefPubMed
13.
go back to reference von Muller L, Klemm A, Weiss M, Schneider M, Suger-Wiedeck H, Durmus N, Hampl W, Mertens T: Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis. 2006, 12: 1517-1522.PubMedCentralCrossRefPubMed von Muller L, Klemm A, Weiss M, Schneider M, Suger-Wiedeck H, Durmus N, Hampl W, Mertens T: Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis. 2006, 12: 1517-1522.PubMedCentralCrossRefPubMed
14.
go back to reference Heidecke CD, Hensler T, Weighardt H, Zantl N, Wagner H, Siewert JR, Holzmann B: Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg. 1999, 178: 288-292.CrossRefPubMed Heidecke CD, Hensler T, Weighardt H, Zantl N, Wagner H, Siewert JR, Holzmann B: Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg. 1999, 178: 288-292.CrossRefPubMed
15.
go back to reference Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, Tattevin P, Thomas R, Fauchet R, Drenou B: Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002, 18: 487-494.CrossRefPubMed Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, Tattevin P, Thomas R, Fauchet R, Drenou B: Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002, 18: 487-494.CrossRefPubMed
16.
go back to reference Christou NV, Meakins JL, Gordon J, Yee J, Hassan-Zahraee M, Nohr CW, Shizgal HM, MacLean LD: The delayed hypersensitivity response and host resistance in surgical patients. 20 years later. Ann Surg. 1995, 222: 534-546.PubMedCentralCrossRefPubMed Christou NV, Meakins JL, Gordon J, Yee J, Hassan-Zahraee M, Nohr CW, Shizgal HM, MacLean LD: The delayed hypersensitivity response and host resistance in surgical patients. 20 years later. Ann Surg. 1995, 222: 534-546.PubMedCentralCrossRefPubMed
17.
go back to reference Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med. 2008, 14: 64-78.PubMedCentralCrossRefPubMed Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med. 2008, 14: 64-78.PubMedCentralCrossRefPubMed
18.
go back to reference Davis JS, Anstey NM: Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis. Crit Care Med. 2011, 39: 380-385.CrossRefPubMed Davis JS, Anstey NM: Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis. Crit Care Med. 2011, 39: 380-385.CrossRefPubMed
19.
go back to reference Taheri F, Ochoa JB, Faghiri Z, Culotta K, Park HJ, Lan MS, Zea AH, Ochoa AC: L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res. 2001, 7: 958s-965s.PubMed Taheri F, Ochoa JB, Faghiri Z, Culotta K, Park HJ, Lan MS, Zea AH, Ochoa AC: L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res. 2001, 7: 958s-965s.PubMed
21.
go back to reference Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, Ochoa JB, Ochoa AC: L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol. 2003, 171: 1232-1239.CrossRefPubMed Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, Ochoa JB, Ochoa AC: L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol. 2003, 171: 1232-1239.CrossRefPubMed
22.
go back to reference Munder M, Schneider H, Luckner C, Giese T, Langhans CD, Fuentes JM, Kropf P, Mueller I, Kolb A, Modolell M, Ho AD: Suppression of T-cell functions by human granulocyte arginase. Blood. 2006, 108: 1627-1634.CrossRefPubMed Munder M, Schneider H, Luckner C, Giese T, Langhans CD, Fuentes JM, Kropf P, Mueller I, Kolb A, Modolell M, Ho AD: Suppression of T-cell functions by human granulocyte arginase. Blood. 2006, 108: 1627-1634.CrossRefPubMed
23.
go back to reference Poschke I, Kiessling R: On the armament and appearances of human myeloid-derived suppressor cells. Clin Immunol. 2012, 144: 250-268.CrossRefPubMed Poschke I, Kiessling R: On the armament and appearances of human myeloid-derived suppressor cells. Clin Immunol. 2012, 144: 250-268.CrossRefPubMed
24.
go back to reference Bryk JA, Popovic PJ, Zenati MS, Munera V, Pribis JP, Ochoa JB: Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. J Trauma. 2010, 68: 843-852.PubMed Bryk JA, Popovic PJ, Zenati MS, Munera V, Pribis JP, Ochoa JB: Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. J Trauma. 2010, 68: 843-852.PubMed
25.
go back to reference Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW, Ulfman LH, Leenen LP, Pickkers P, Koenderman L: A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. 2012, 122: 327-336.PubMedCentralCrossRefPubMed Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW, Ulfman LH, Leenen LP, Pickkers P, Koenderman L: A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. 2012, 122: 327-336.PubMedCentralCrossRefPubMed
26.
go back to reference Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O’Malley KA, Wynn JL, Antonenko S, Al-Quran SZ, Swan R, Chung CS, Atkinson MA, Ramphal R, Gabrilovich DI, Reeves WH, Ayala A, Phillips J, Laface D, Heyworth PG, Clare-Salzler M, Moldawer LL: MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med. 2007, 204: 1463-1474.PubMedCentralCrossRefPubMed Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O’Malley KA, Wynn JL, Antonenko S, Al-Quran SZ, Swan R, Chung CS, Atkinson MA, Ramphal R, Gabrilovich DI, Reeves WH, Ayala A, Phillips J, Laface D, Heyworth PG, Clare-Salzler M, Moldawer LL: MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med. 2007, 204: 1463-1474.PubMedCentralCrossRefPubMed
27.
go back to reference Kong YY, Fuchsberger M, Xiang SD, Apostolopoulos V, Plebanski M: Myeloid derived suppressor cells and their role in diseases. Curr Med Chem. 2013, 20: 1437-1444.CrossRefPubMed Kong YY, Fuchsberger M, Xiang SD, Apostolopoulos V, Plebanski M: Myeloid derived suppressor cells and their role in diseases. Curr Med Chem. 2013, 20: 1437-1444.CrossRefPubMed
29.
go back to reference Poschke I, Mao Y, Adamson L, Salazar-Onfray F, Masucci G, Kiessling R: Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines. Cancer Immunol Immunother. 2012, 61: 827-838.CrossRefPubMed Poschke I, Mao Y, Adamson L, Salazar-Onfray F, Masucci G, Kiessling R: Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines. Cancer Immunol Immunother. 2012, 61: 827-838.CrossRefPubMed
30.
go back to reference Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O’Neill A, Mier J, Ochoa AC: Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005, 65: 3044-3048.PubMed Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O’Neill A, Mier J, Ochoa AC: Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005, 65: 3044-3048.PubMed
31.
go back to reference Schmielau J, Finn OJ: Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 2001, 61: 4756-4760.PubMed Schmielau J, Finn OJ: Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 2001, 61: 4756-4760.PubMed
32.
go back to reference van den Akker EL, Baan CC, van den Berg B, Russcher H, Joosten K, Hokken-Koelega AC, Lamberts SW, Koper JW: Ficoll-separated mononuclear cells from sepsis patients are contaminated with granulocytes. Intensive Care Med. 2008, 34: 912-916.CrossRefPubMed van den Akker EL, Baan CC, van den Berg B, Russcher H, Joosten K, Hokken-Koelega AC, Lamberts SW, Koper JW: Ficoll-separated mononuclear cells from sepsis patients are contaminated with granulocytes. Intensive Care Med. 2008, 34: 912-916.CrossRefPubMed
33.
go back to reference Lazarus AH, Ellis J, Blanchette V, Freedman J, Sheng-Tanner X: Permeabilization and fixation conditions for intracellular flow cytometric detection of the T-cell receptor zeta chain and other intracellular proteins in lymphocyte subpopulations. Cytometry. 1998, 32: 206-213.CrossRefPubMed Lazarus AH, Ellis J, Blanchette V, Freedman J, Sheng-Tanner X: Permeabilization and fixation conditions for intracellular flow cytometric detection of the T-cell receptor zeta chain and other intracellular proteins in lymphocyte subpopulations. Cytometry. 1998, 32: 206-213.CrossRefPubMed
35.
go back to reference Wang H, McNeil YR, Yeo TW, Anstey NM: Simultaneous determination of multiple amino acids in plasma in critical illness by high performance liquid chromatography with ultraviolet and fluorescence detection. J Chromatogr B. 2013, 940: 53-58.CrossRef Wang H, McNeil YR, Yeo TW, Anstey NM: Simultaneous determination of multiple amino acids in plasma in critical illness by high performance liquid chromatography with ultraviolet and fluorescence detection. J Chromatogr B. 2013, 940: 53-58.CrossRef
36.
go back to reference Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Gladwin MT: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005, 294: 81-90.PubMedCentralCrossRefPubMed Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Gladwin MT: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005, 294: 81-90.PubMedCentralCrossRefPubMed
37.
go back to reference Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, McNeil YR, Cheng AC, Celermajer DS, Stephens DP, Anstey NM: Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care. 2009, 13: R155-PubMedCentralCrossRefPubMed Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, McNeil YR, Cheng AC, Celermajer DS, Stephens DP, Anstey NM: Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care. 2009, 13: R155-PubMedCentralCrossRefPubMed
38.
go back to reference Elghetany MT: Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis. 2002, 28: 260-274.CrossRefPubMed Elghetany MT: Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis. 2002, 28: 260-274.CrossRefPubMed
39.
go back to reference Tacke RS, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR, Hahn YS: Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology. 2012, 55: 343-353.PubMedCentralCrossRefPubMed Tacke RS, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR, Hahn YS: Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology. 2012, 55: 343-353.PubMedCentralCrossRefPubMed
40.
go back to reference Garg A, Spector SA: HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J Infect Dis. 2014, 209: 441-451.PubMedCentralCrossRefPubMed Garg A, Spector SA: HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J Infect Dis. 2014, 209: 441-451.PubMedCentralCrossRefPubMed
41.
go back to reference Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schafer I, Wecker I, Neri D, Wirth A, Mays L, Zundel S, Fuchs J, Handgretinger R, Stern M, Hogardt M, Döring G, Riethmüller J, Kormann M, Hartl D: Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol. 2013, 190: 1276-1284.CrossRefPubMed Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schafer I, Wecker I, Neri D, Wirth A, Mays L, Zundel S, Fuchs J, Handgretinger R, Stern M, Hogardt M, Döring G, Riethmüller J, Kormann M, Hartl D: Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol. 2013, 190: 1276-1284.CrossRefPubMed
42.
go back to reference De Santo C, Salio M, Masri SH, Lee LY, Dong T, Speak AO, Porubsky S, Booth S, Veerapen N, Besra GS, Gröne HJ, Platt FM, Zambon M, Cerundolo V: Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest. 2008, 118: 4036-4048.PubMedCentralCrossRefPubMed De Santo C, Salio M, Masri SH, Lee LY, Dong T, Speak AO, Porubsky S, Booth S, Veerapen N, Besra GS, Gröne HJ, Platt FM, Zambon M, Cerundolo V: Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest. 2008, 118: 4036-4048.PubMedCentralCrossRefPubMed
43.
go back to reference Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M, Blander JM, Tacke F, Trautwein C: Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med. 2010, 207: 1453-1464.PubMedCentralCrossRefPubMed Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M, Blander JM, Tacke F, Trautwein C: Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med. 2010, 207: 1453-1464.PubMedCentralCrossRefPubMed
44.
go back to reference Fullerton JN, O’Brien AJ, Gilroy DW: Pathways mediating resolution of inflammation: when enough is too much. J Pathol. 2013, 231: 8-20.CrossRefPubMed Fullerton JN, O’Brien AJ, Gilroy DW: Pathways mediating resolution of inflammation: when enough is too much. J Pathol. 2013, 231: 8-20.CrossRefPubMed
45.
go back to reference Giamarellos-Bourboulis EJ: What is the pathophysiology of the septic host upon admission?. Int J Antimicrob Agents. 2010, 36: S2-S5.CrossRefPubMed Giamarellos-Bourboulis EJ: What is the pathophysiology of the septic host upon admission?. Int J Antimicrob Agents. 2010, 36: S2-S5.CrossRefPubMed
46.
go back to reference Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ: Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009, 58: 49-59.PubMedCentralCrossRefPubMed Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ: Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009, 58: 49-59.PubMedCentralCrossRefPubMed
47.
go back to reference Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O’Shea JJ, Kudoh S, Klein E, Bukowski RM, Ochoa AC: Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 1993, 53: 5613-5616.PubMed Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O’Shea JJ, Kudoh S, Klein E, Bukowski RM, Ochoa AC: Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 1993, 53: 5613-5616.PubMed
48.
go back to reference Gunji Y, Hori S, Aoe T, Asano T, Ochiai T, Isono K, Saito T: High frequency of cancer patients with abnormal assembly of the T cell receptor-CD3 complex in peripheral blood T lymphocytes. Jpn J Cancer Res. 1994, 85: 1189-1192.CrossRefPubMed Gunji Y, Hori S, Aoe T, Asano T, Ochiai T, Isono K, Saito T: High frequency of cancer patients with abnormal assembly of the T cell receptor-CD3 complex in peripheral blood T lymphocytes. Jpn J Cancer Res. 1994, 85: 1189-1192.CrossRefPubMed
49.
go back to reference Matsuda M, Ulfgren AK, Lenkei R, Petersson M, Ochoa AC, Lindblad S, Andersson P, Klareskog L, Kiessling R: Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol. 1998, 47: 254-262.CrossRefPubMed Matsuda M, Ulfgren AK, Lenkei R, Petersson M, Ochoa AC, Lindblad S, Andersson P, Klareskog L, Kiessling R: Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol. 1998, 47: 254-262.CrossRefPubMed
50.
go back to reference Liossis SN, Ding XZ, Dennis GJ, Tsokos GC: Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest. 1998, 101: 1448-1457.PubMedCentralCrossRefPubMed Liossis SN, Ding XZ, Dennis GJ, Tsokos GC: Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest. 1998, 101: 1448-1457.PubMedCentralCrossRefPubMed
51.
go back to reference Baniyash M: TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol. 2004, 4: 675-687.CrossRefPubMed Baniyash M: TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol. 2004, 4: 675-687.CrossRefPubMed
52.
go back to reference Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC: Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009, 69: 1553-1560.PubMedCentralCrossRefPubMed Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC: Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009, 69: 1553-1560.PubMedCentralCrossRefPubMed
53.
go back to reference Goddard DS, Yamanaka K, Kupper TS, Jones DA: Activation of neutrophils in cutaneous T-cell lymphoma. Clin Cancer Res. 2005, 11: 8243-8249.CrossRefPubMed Goddard DS, Yamanaka K, Kupper TS, Jones DA: Activation of neutrophils in cutaneous T-cell lymphoma. Clin Cancer Res. 2005, 11: 8243-8249.CrossRefPubMed
54.
go back to reference Lechner MG, Liebertz DJ, Epstein AL: Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 2010, 185: 2273-2284.PubMedCentralCrossRefPubMed Lechner MG, Liebertz DJ, Epstein AL: Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 2010, 185: 2273-2284.PubMedCentralCrossRefPubMed
55.
go back to reference Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S: Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 2007, 67: 10019-10026.PubMedCentralCrossRefPubMed Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S: Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 2007, 67: 10019-10026.PubMedCentralCrossRefPubMed
56.
go back to reference Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF: Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006, 368: 157-169.CrossRefPubMed Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF: Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006, 368: 157-169.CrossRefPubMed
57.
go back to reference Valitutti S, Muller S, Dessing M, Lanzavecchia A: Signal extinction and T cell repolarization in T helper cell-antigen-presenting cell conjugates. Eur J Immunol. 1996, 26: 2012-2016.CrossRefPubMed Valitutti S, Muller S, Dessing M, Lanzavecchia A: Signal extinction and T cell repolarization in T helper cell-antigen-presenting cell conjugates. Eur J Immunol. 1996, 26: 2012-2016.CrossRefPubMed
Metadata
Title
Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients
Authors
Christabelle J Darcy
Gabriela Minigo
Kim A Piera
Joshua S Davis
Yvette R McNeil
Youwei Chen
Alicia D Volkheimer
J Brice Weinberg
Nicholas M Anstey
Tonia Woodberry
Publication date
01-08-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc14003

Other articles of this Issue 4/2014

Critical Care 4/2014 Go to the issue